ID 32044
JaLCDOI
FullText URL
Author
Kimura, Ikuro
Ohnoshi, Taisuke
Nakata, Yasunari
Takasugi, Kenta
Fujii, Masafumi
Hayashi, Kyoichi
Sato, Masaharu
Nishihara, Ryuji
Abstract

Clinical trials of immuno-chemotherapy were conducted on malignant lymphoma patients. Patients during the period from 1972 through 1977 were allocated to two groups retrospectively according to the mode of treatment, i.e., chemotherapy alone (historical control group, 35 patients) and chemotherapy with OK-432 (treated group, 15 patients). Comparisons were made of the two groups, which were homogeneous with regard to induction chemotherapy, maintenance chemotherapy, stage and histologic type of disease. The treated group had a higher remission rate, and a longer remission duration and survival than the control groups, especially in patients with Hodgkin's disease but the difference was not statistically significant owing to the limited number of cases.

Keywords
malignant lymphoma
chemotherapy
nonspecific immunotherapy
OK-432
Amo Type
Article
Published Date
1979-12
Publication Title
Acta Medica Okayama
Volume
volume33
Issue
issue6
Publisher
Okayama University Medical School
Start Page
471
End Page
478
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
英語
File Version
publisher
Refereed
True
PubMed ID
NAID